Treating Immune Deficiency and Related Infections in People With Kaposi Sarcoma

The most important treatment for Kaposi sarcoma (KS) is treating any immune deficiency that exists as well as any related infections.

In people with AIDS, this means using combinations of anti-HIV drugs. This is known as highly active antiretroviral therapy (HAART). For many AIDS patients, HAART may be the only treatment needed to cause the KS lesions to shrink and to keep them under control.

In organ-transplant patients whose immune systems are suppressed by drugs, decreasing or changing the drugs may be helpful.

New KS lesions are more likely to develop when a patient’s blood test results for Kaposi sarcoma herpesvirus (KSHV) are positive. The risk of developing new lesions is lower when antiviral medicines such as ganciclovir or foscarnet are used. These medicines may help prevent new lesions but they do not help existing lesions get better. They are also costly and can cause serious side effects.

KS lesions tend to get worse if you develop bacterial or other active infections. Therefore, it is very important to do what you can to lower your risk of bacterial infections and to treat active infections promptly if they do occur.

The American Cancer Society medical and editorial content team
Our team is made up of doctors and master's-prepared nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

Last Medical Review: August 8, 2014 Last Revised: February 9, 2016

American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.